Jabalpur: Doctors treat a patient infected with black fungus at NSCB Medical College and Hospital, in Jabalpur, Friday, May 21, 2021. (PTI Photo)(PTI05_21_2021_000101A) (PTI)
Jabalpur: Doctors treat a patient infected with black fungus at NSCB Medical College and Hospital, in Jabalpur, Friday, May 21, 2021. (PTI Photo)(PTI05_21_2021_000101A) (PTI)

‘3.6% of hospitalised Covid-19 patients had fungal, bacterial infections’: ICMR study

Just as cases of black fungus are being reported in Covid-19 patients during the second wave of the pandemic, secondary bacterial and fungal infections affected at least 3
PUBLISHED ON MAY 24, 2021 10:23 PM IST

Just as cases of black fungus are being reported in Covid-19 patients during the second wave of the pandemic, secondary bacterial and fungal infections affected at least 3.6% (ranging from 1.7% to 28% between hospitals) of the hospitalised patient with coronavirus disease (Covid-19) during the last wave, found a study by the Indian Council of Medical Research (ICMR) published on Monday.

The mortality in patients with these secondary infections increased to 56.7% as against 10.6% among the hospitalised patients in the ten network hospitals from where data was collected. The mortality in those with secondary infections was as high as 78.9% in one of the hospitals, the data shows.

“What we found was that most of these secondary infections, 78% of them, were acquired at the hospital; the indication for infections started two days after hospitalisation and most of the samples had gram-negative bacteria showing that they were hospital-based infections. This could be because infection control policies at the hospitals went for a toss amidst the pandemic. Hand hygiene wasn’t as good because of double gloving and use of PPE kits in the hot weather also added to it,” said Dr Kamini Walia, corresponding author of the paper and scientist with the epidemiology and communicable diseases department at the (ICMR).

She added, “The most common pathogens causing the infections were Klebsiella pneumonia and Acinetobacter baumannii; usually E Coli is the most common pathogen found as per the previous ICMR reports. Both infections are very difficult to treat because they have acquired a lot of resistant genes over time. The treatment will further become difficult post-Covid. Hospitals must invest in infection control and rationalise antimicrobial prescriptions.”

Interestingly, the hospitals did not report cases of the fungal infection mucormycosis, cases of which have exploded during the second wave.

“We have a double whammy; Covid-19, along with the secondary infections, increases mortality significantly. We saw primarily bacterial infection as reported in the study; mucormycosis cases being reported after the second wave is largely to do with the overuse of steroids. At the peak, steroids had vanished from the market. This has never happened before; it is one of the most common medicines available,” said Dr Chand Wattal, head of the department of microbiology at Sir Ganga Ram hospital, one of the ten centres that were included in the study.

More importantly, the study cautions about the increase in antimicrobial resistance in the coming years due to excessive use of stronger medicines. Around 74.4% of the total antimicrobials prescribed in the hospitals were from the Watch and Reserve category of the World Health Organisation (WHO).

The WHO classifies all antibiotics in three categories – Access drugs that can treat commonly encountered pathogens and have lower resistance potential, Watch drugs that have higher resistance potential and are critical for treatment, and Reserve drugs that need to be saved as last resort for drug-resistant microbes and given only once an infection is confirmed.

“Around 47% of the infections were found to be multi-drug resistant but more than 74% of the antimicrobials prescribed were from the Watch and Reserve category. And, the ten hospitals from where we have collected data are in the ICMR network, they have been trained in infection control and antimicrobial stewardship. We can only imagine what is happening in other hospitals,” said Dr Walia.

“These hospitals are backed by good lab facilities and many of these antibiotics should be prescribed only after the culture test comes positive. However, a very low number of samples were collected for microbial culture,” she said.

Of the 17,534 patients with Covid-19 admitted to the ten hospitals between 1 June 2020 and 30 August 2020, only 7,163 samples were sent for microbial culture – with multiple samples being from the same patients. The low sampling, doctors said, was because of the practical problems, not many healthcare workers wanted to collect these samples during the first wave when not much was known about the disease.

“The sample size decreased considerably because people were scared to take the samples, especially those that generate aerosols such as lavage (a procedure where the lower respiratory tract is flushed with fluid which is collected for diagnosis). The sampling has increased now that people are aware of how to protect themselves,” said Dr Wattal.

“This is the chicken or the egg situation. We use stronger antibiotics because there are many resistant infections, but because we use these antibiotics we put more pressure on the pathogens to become further resistant. Say, we send out samples of 100 patients for culture, only 40 come back positive but the others have the signs and symptoms of an infection, so we prescribe antibiotics to all depending on the type of pathogens found in the 40 samples. Second, the culture takes a couple of days but in the meantime, we have to prescribe medicines empirically. But, there is no doubt we use a lot of antibiotics,” said Dr Sumit Ray, critical care specialist from Holy Family Hospital.

“We need to de-escalate once the culture report comes, we need to prescribe based on whether the infection was acquired in the community or the hospital, there should be a restricted antibiotic policy where the doctor has to explain to a committee why the higher antibiotics are being used. There have to be several levels of checks and balances,” he said.

There are no guidelines on the rational use of antimicrobial in Covid-19 patients by the ICMR.

SHARE THIS ARTICLE ON
Close
SHARE
Story Saved
OPEN APP